Agents effective against intracellular pathogens must enter infected cells, crossing vacuolar membranes surrounding the organisms and then penetrating into the microbe and localizing to the microbial target site. We have characterized these parameters for azithromycin entry into Toxoplasma gondii-infected Chinese hamster ovary cells and murine macrophage-like J774 cells. Azithromycin uptake into infected host cells was concentrative and was dependent upon proton gradients. Antibiotics of the macrolide class concentrate in cells in acidified compartments, particularly lysosomes (7). This characteristic may in part explain the activity of macrolides against certain intracellular pathogens (37, 19, 37). A number of intracellular microorganisms, however, reside in vacuoles inside cells which are not acidified (reviewed in reference 28). The subcellular distribution of macrolides in cells infected with these organisms is not known.
Antibiotics of the macrolide class concentrate in cells in acidified compartments, particularly lysosomes (7) . This characteristic may in part explain the activity of macrolides against certain intracellular pathogens (37, 19, 37) . A number of intracellular microorganisms, however, reside in vacuoles inside cells which are not acidified (reviewed in reference 28). The subcellular distribution of macrolides in cells infected with these organisms is not known.
Toxoplasma gondii is an obligate intracellular protozoan parasite capable of producing severe infection in immunocompromised hosts (27) . The actively replicating tachyzoite form of the parasite resides and multiplies in cells within a vacuole which does not acidify (36) or fuse with lysosomes (23, 25) . Clindamycin as well as the newer macrolides and azalides is reported to have activity against T. gondii both in vitro and in vivo (1, 4, 5, 8-10, 16, 17, 31, 32) . The concentration of drug reported to inhibit parasite growth in vitro varies over several orders of magnitude, however, depending upon the specific assay conditions (8, 10, 22, 32) . Since azithromycin achieves striking intracellular concentrations in uninfected cells (20, 21) , we initiated studies on the subcellular distribution of azithromycin in T. gondii-infected cells. Our results indicate that drug accumulation in infected cells is localized to acidified organelles of the parasite and the host cell and is not concentrated in pathogen-containing vacuoles which are not acidified.
(This work was presented in part at the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, Calif., October 1992 [abstr. 328]).
Host cells. Experiments evaluating antibiotic uptake in T. gondii-infected cells used either Chinese hamster ovary fibroblasts or murine macrophage-like J774 cells. CHO cells were plated onto 100-mm-diameter plastic petri dishes in aMEM plus 3.5% heat-inactivated fetal calf serum and were incubated at 37°C (5% CO2), with splitting of the monolayers when they were confluent. Adherent cells were released from petri dishes by a 5-min incubation (37°C) with trypsin solution and were washed. J774 murine macrophage-like cells were grown in spinner culture at 37°C (5% CO2) in aMEM containing 3.5% fetal calf serum.
Assay for antibiotic uptake. Antibiotic uptake into cells and parasites was measured by the oil stop technique (13) . Cell suspensions were first mixed with ['4C]azithromycin (10 ,ug/ml final concentration). At subsequent intervals, triplicate 60-pI aliquots of the cell suspension were applied to 400-,ul microcentrifuge tubes containing 25 RI of 15% trichloroacetic acid (TCA) overlaid with 125 RI of a mixture of 84% 550 silicon fluid (Dow, Midland, Mich.) and 16% light paraffin oil (Fisher, Fair Lawn, N.J.). The cells with incorporated radioactivity were then pelleted into the TCA layer by centrifuging in a microcentrifuge at 15 ,000 x g for 30 s. The tubes were then sliced through the oil layer, and the radioactivity present in the top and bottom halves was determined by liquid scintillation counting. The intracellular volume of the cells and the correction required for radioactivity present in extracellular medium carried into the TCA layer by the pelleting cells were determined by using 3H20 and [14C]inulin as described previously (13) . Intracellular azithromycin concentrations and apparent intracellular to extracellular (I/E) ratios were calculated assuming that the drug was uniformly distributed within the total intracellular space of the cells. Although this assumption provides a value for the average intracellular concentration of the antibiotic, specific intracellular compartments may achieve concentrations higher or lower than this average level (6; this paper).
Proton gradient disruption. The requirement of intracellular proton gradients for accumulation of azithromycin within uninfected CHO cells was examined as a prelude to experiments with infected CHO cells. Proton gradients were disrupted by using monensin. CHO Cells were disrupted by being passed three times through an iced ball bearing homogenizer (6/10,000-in. clearance; Bernitech, Redwood City, Calif.) (2) , resulting in greater than 90% cell disruption. Under these conditions, the parasitophorous vacuole containing the intracellular parasites is disrupted (30) , and parasites were found dispersed in the homogenization buffer. The cell homogenate was applied to the top of a step sucrose density gradient (0.8 M, 1.1 M, 1.7 M, and 2.1 M sucrose in PBS over a 2.5 M CsCl cushion for gradients [see Fig. 1 ] and 0.8 M, 1.1 M, 1.3 M, 1.5 M, 1.7 M, 1.9 M, and 2.1 M sucrose in PBS over a 2.5 M CsCl cushion for gradients [see Fig. 3] ). Gradients were centrifuged at 98,000 x g for either 3.5 h (see Fig. 1 for gradients) or for 17 h (see Fig. 3 for gradients) in an SW41 rotor in an L8-70M ultracentrifuge (Beckman, Fullerton, Calif.). The gradient was unloaded from the bottom in 0.5-ml fractions with a density gradient fractionator (Isco, Lincoln, Nebr.), and fractions were assayed for refractive index (refractometer from Milton Roy Co., Arvada, Colo.), [ (parasite/cell ratio of 10:1), and mixtures were rotated for 1 h at 37°C in 5% CO2. For some tubes, tachyzoites were incubated for 20 min at room temperature with a 1:50 dilution of rabbit anti-T gondii antiserum prior to the addition of parasites to the J774 cells. Following the 1-h incubation, J774 cells were pelleted by centrifugation at 80 x g for 5 min at 4°C. This procedure was repeated twice. Under these conditions, infected and noninfected cells pelleted, while unattached parasites remained in the supernatant. The cell pellet was resuspended in aMEM to 10 cells per ml, and [4C]azithromycin was added to a final concentration of 10 ,g/ml. The mixtures were incubated for 1 h at 37°C, and then cells were washed twice in PBS and once in TEA. J774 cells were disrupted by three passages through an iced ball bearing homogenizer with a clearance of 6/10,000 inch. The lysate was centrifuged twice at 80 x g for 5 min each time to remove nuclei and cellular debris. The supematant was loaded onto a 40% self-generating Percoll gradient, which was centrifuged for 30 min at 22,000 x g at 4°C. Gradients were fractionated and processed as described above.
Macrolide efflux from host cells and subcellular fractionation. The potential concentration or retention of azithromycin in the parasite compartment during effiux of antibiotic from then washed twice with cold PBS, fresh azithromycin-free medium was added, and the dishes were returned to the 37°C incubator. At intervals of 0, 1.5, and 3 h, the cells were washed four times with PBS, trypsinized, washed once each with otMEM and TEA buffer, and homogenized as described above. Postnuclear supernatants were applied to sucrose density gradients, which were then centrifuged at 98,000 x g for 17 h at 40C in an SW41 rotor. Gradients were then fractionated and assessed for 3-hexosaminidase activity, [14C]azithromycin content, refractive index, and parasite number as described above.
Azithromycin uptake by extracellular T. gondii. Uptake of azithromycin into extracellular parasites was examined in several buffers: HBSS buffer; the potassium chloride-based AISS buffer (pH 7.2), designed to mimic the intracellular ionic milieu; or VA-13 medium, a defined medium reported to maintain extended parasite viability as assessed by purine nucleoside incorporation (26) . Aliquots of parasites (-2 x 108/ml) were mixed with an equal volume of 20 ,ug of azithromycin per ml (yielding a final concentration of 10 ,ug of azithromycin per ml. At intervals after mixing, 60-,u aliquots of the parasite suspension were transferred to oil stop tubes, centrifuged, and analyzed as described above for uptake into host cells.
The effect of pH and temperature upon tachyzoite uptake of azithromycin was tested. Parasites were suspended in HBSS buffers of pH 6.0, 7.3, or 8.0, and drug uptake was measured over 30 min. Thirty-minute azithromycin uptake by parasites was also evaluated at 4, 24, and 37°C (pH 7.3). The effect of proton gradient ablation was examined by using 10 ,uM monensin or 50 mM NH4Cl. Parasites (1.5 x 108/ml) were divided into four alitots (a to d), pelleted, and then resuspended in either VA-13 (pH 7.5) (samples a and b), VA later for determination of cell-associated antibiotic content by centrifugation through oil as described above.
RESULTS
Azithromycin uptake by host cells. We initially examined several parameters previously reported to influence azithromycin uptake into cells (20, 21) . A ratio of intracellular to extracellular drug concentration greater than 1 indicates concentration of drug within cells. After 10 min of uptake at 37°C, CHO cells had already attained an I/E ratio of -15. This rapid intracellular accumulation has been characterized as consistent with lysosomotropism (21) . Supporting this contention, we found that azithromycin uptake into CHO cells was effectively blocked by treatment with the proton ionophore monensin (10 ,uM) . Monensin-treated CHO cells accumulated only 4.8% ± 5.8% and 3.3% ± 4.1% as much cell-associated azithromycin as non-monensin-treated cells at 10 and 30 min following the addition of azithromycin. With a correction for azithromycin trapped during pelleting through oil, this block of azithromycin uptake into monensin-treated cells was essentially complete.
Cellular processes such as phagocytosis may alter drug uptake (20, 37) . T. gondii invasion of host cells differs from classical phagocytosis (23) . We nonetheless found no significant difference between rapid concentrative azithromycin uptake by T gondii-infected or uninfected murine macrophagelike J774 cells (data not shown) and that by CHO cells (see below); these results are similar to results presented by Blais (4) . As noted previously, such experiments assume that the drug is distributed uniformly throughout the cell; they yield no information about drug concentrations in specific intracellular compartments (6; this paper). To (Fig. 1A) . Azithromycin was found in both heavy (density, 1.21 g/ml) and light (density, 1.12 g/ml) lysosome fractions (indicated by arrows). The sedimentation profile of parasites in this gradient was then determined by using extracellular tachyzoites loaded with ["4C]azithromycin (Fig.   1B) . When T. gondii-infected CHO cells loaded with azithromycin were fractionated (Fig. 1C) , only a small portion of the drug was found in the parasite fractions compared with host-cell cytoplasmic or lysosome fractions. In infected cells, the sedimentation of lysosomes and parasites was not altered in comparison with uninfected cells and extracellular parasites. In duplicate experiments, the T. gondii-containing fractions of infected CHO cells contained an average of 18.5% ± 9.6% of the total ["4C]azithromycin present, versus 18.3% ± 1.4% for the identical fractions in uninfected CHO cells. The large variability in the data with infected CHO cells may be explained by the long-recognized wide variation in day-to-day infectivity of extracellular parasites (11, 33) , since any difference in initial parasite infectivity between the experiments would have been amplified over the subsequent 18-h incubation. When infected cells were instead fractionated on a 32% self-generating Percoll gradient, 16.1% of the azithromycin was present in parasite-containing fractions, versus 14.0% for identical fractions from uninfected CHO cells (data not shown). Together, these data indicate that less than 5% of the total intracellular azithromycin localized specifically to the C. Cells were loaded with 10 ,ug of azithromycin per ml for 35 min at 37°C, disrupted by ball bearing homogenization, and fractionated on sucrose density gradients as described in Materials and Methods. Data are from a single experiment and are representative of three experiments. intracellular parasite. These results are consistent with the failure of the T. gondii vacuole to acidify (36) .
Subcellular distribution of azithromycin in infected J774 cells. To explore further the relationship between vacuole acidification and azithromycin uptake, experiments using J774 murine macrophage-like cells were conducted. Internalization of antibody-coated T. gondii by cells expressing Fc receptors results in vacuole fusion with lysosomes and vacuole acidification (5, 23, 24) . Azithromycin uptake into the parasite-containing fractions was therefore compared for either native or antibody-coated parasites entering J774 cells. For cells infected with native parasites, 21% of the total cell-associated azithromycin localized in the parasite-containing fractions, compared with only 9% in the same fractions from noninfected cells a Murine macrophage-like J774 cells were infected for 1 h at a 10:1 parasite: cell ratio either with native T. gondii tachyzoites or with tachyzoites previously incubated with anti-T. gondii antiserum. Cells were then processed as ( Table 1 ). Thus, 12% (i.e., 21% minus 9%) of the total cell-associated azithromycin was specifically associated with the parasite fraction in infected cells. This percentage is substantially higher than that for CHO cells and in part reflects the fact that under these conditions 1/3 of parasites are in acidified vacuoles (23) . Internalization of antibody-coated parasites increased the specific fraction of parasite-associated azithromycin to 20% (i.e., 29% minus 9%). Under these conditions, over 80% of parasites are in acidified vacuoles (23) . These results further support the notion that azithromycin concentrates preferentially in vacuoles which are acidified. Macrolide efflux from host cells and subcellular fractionation. We considered the possibility that azithromycin was specifically retained and/or concentrated in the T. gondii vacuole during drug efflux from antibiotic-loaded cells. As shown in Fig. 2 intervals during drug efflux (Fig. 3) . At time zero, azithromycin was located primarily in host cell lysosomes (Fig. 3A) and not in the parasite-containing fractions, as expected from the results shown in Fig. 1 . In the experiment illustrated in Fig. 3A , azithromycin was distributed primarily in the light fraction of host cell lysosomes (density, 1.12, corresponding to the upper peak of ,B-hexosaminidase activity), although in other efflux experiments the distributions between the heavy and light lysosome peaks were nearly equivalent. A much smaller amount of azithromycin was present in the cytosol fraction (delnsity, < 1.07 g/ml) of the gradient relative to Fig. 1 , because of rapid efflux of the drug from the cytosolic compartment during the 37°C incubation required for trypsinizing the monolayer. Only a small fraction of azithromycin was associated with the parasite, confirming the results in Fig. 1 . After 1.5 ( Fig. 3B)  and 3 (Fig. 3C) h of incubation at 37°C in azithromycin-free media, the amounts of azithromycin present in lysosomal and cytoplasmic fractions decreased. The minor azithromycin peak associated with the parasites at time zero was absent at 1.5 and 3 h, while the numbers of parasites increased over these same intervals. Therefore, by several criteria, we could not demonstrate specific retention of azithromycin in T. gondii-infected cells.
Azithromycin uptake by extracellular T. gondii. We next examined parameters affecting azithromycin uptake into extracellular parasites as an indicator of uptake of the drug by the intracellular pathogen. Uptake into tachyzoites was rapid and time, temperature and pH dependent. For parasites, a mean I/E ratio of 36.1 ± 9.2 was observed after 30 min of incubation at 37°C in HBSS (pH 7.3) (five experiments). Intracellular accumulation was markedly influenced by extracellular buffer pH (Fig. 4A) , presumably because of an increased amount of nonprotonated (membrane-diffusible) drug at higher pH (7) . Decreasing the incubation temperature to 24 or 4°C decreased uptake over the same period (Fig. 4B) . Comparison of T gondii uptake in buffers with ionic compositions emulating the extracellular (HBSS) and intracellular (AISS) environments revealed delayed accumulation of azithromycin in AISS (Fig.  5) . Given that the weak base azithromycin accumulates in acidic compartments, this finding indirectly confirms the earlier observation that extracellular T. gondii acidifies more rapidly in low-potassium buffers than in high-potassium buffers (18) . The convergence of levels of azithromycin uptake at the later time points may reflect gradual acidification of tachyzoites in the AISS buffer, ongoing accumulation of protonated drug in acidic cellular organelles (which may predominate over time [14] ), or a combination of both processes. Monensin (10 ,uM) and ammonium chloride (50 mM), agents which obliterate intracellular pH gradients, blocked ongoing azithromycin accumulation in parasites (Fig. 6) gondii. Finally, we tested drug uptake by an azithromycinresistant mutant derived from the RH strain of T gondii. Drug uptake was not significantly different from drug uptake by the wild-type RH strain (Fig. 8) . There was no difference between the kinetics of azithromycin efflux from the azithromycin- 
DISCUSSION
This study demonstrates that >95% of azithromycin loaded into T. gondii-infected CHO cells concentrates in cell lysosomes and cytosol and not in the parasite. This result is consistent with the failure of the T. gondii vacuole to fuse with lysosomes or acidify and also with the known lysosomotropism of macrolide and azalide antibiotics. Consistent with this notion, internalization of parasites under conditions leading to the formation of acidified phagolysosomes substantially increased drug accumulation in the parasite-containing fractions. Azithromycin which did enter tachyzoites accumulated in one or more parasite compartments which were presumably acidic (Fig. 6) ; again, this is consistent with lysosomotropic behavior. There was no evidence for selective redistribution or retention of azithromycin in parasites after removal of the drug, since azithromycin effluxing from antibiotic-loaded cells did not redistribute into parasites and since azithromycin effluxing from extracellular parasites was not retained significantly within the parasite. Taken as a whole, these results indicate that azithromycin concentrates in acidified compartments in parasites and host cells but not in pathogen-containing vacuoles which are not acidified. These data suggest the need to consider subcellular drug distributions when evaluating macrolide therapy for other intracellular pathogens which do not reside in acidified compartments. These pathogens include species of Legionella and Chlamydia and also selected Mycobacterium species (reviewed in reference 28).
It is generally agreed that a drug must enter into cells in order to act against intracellular pathogens (35, 37) . Macrolides achieve high intracellular concentrations due to lysosomotropism (7, 21) , concentrating in acidic cellular compartments. Fluoroquinolones also reach elevated concentrations within cells but are not trapped within acidic vacuoles (6) . Of note, when the fluoroquinolone pefloxacin was loaded into Legionella sp.-infected guinea pig macrophages, exaggerated retention of this drug with localization to the pathogenassociated cell fractions was observed (6) . This finding is in striking contrast to the data on efflux of azithromycin from T gondii-infected CHO cells presented here, showing no increased retention of azithromycin in infected compared with uninfected cells and also rapid efflux of drug from pathogenassociated cell fractions as early as 1.5 h after being shifted to azithromycin-free media. The near doubling in parasite number over the 3 h of azithromycin efflux (Fig. 3) suggests that initial parasite replication was not blocked by exposure to azithromycin under these experimental conditions and that parasite growth was rapid in CHO cells. In comparison, a 6-h doubling time has been observed for tachyzoites growing in human foreskin fibroblasts (32) .
The rapid efflux of azithromycin from host cells and parasites demonstrated in the present study differs from the extended retention of azithromycin reported for studies using human fibroblasts (21) and murine peritoneal macrophages (20) . In these earlier studies, however, cells were loaded with 10 ,ug of azithromycin per ml (initial concentration) for 24 h prior to initiation of efflux, conditions which would maximize the drug fraction trapped within lysosomes relative to cytoplasm (14) . In our experiments, host cells and parasites were loaded with the same initial concentration of azithromycin for only 30 min, since azithromycin has been reported to rapidly inhibit intracellular parasite growth (3) and since extracellular parasite survival is limited even in the absence of antimicrobial agents (26) . Differing rates of azithromycin efflux from the cytoplasm and lysosomes of infected CHO cells are clearly demonstrated in Fig. 3 : little azithromycin was found in the cytoplasmic fractions at the earliest time point, but azithromycin persisted in the lysosomal fractions 3 h later. The initial rapid fall in intracellular azithromycin levels followed by the more gradual decline in infected CHO cells seen during efflux (Fig. 2) may reflect predominant release first from the cytoplasmic compartment and then from the lysosomal compartment.
Precise identification of the compartment within which azithromycin accumulates in tachyzoites has not been made. Typical lysosomes have not been described morphologically, although anterior vesicular structures which accumulate the lysosomotropic dye acridine orange have been reported (29) . The pH of intracellular T. gondii cytosol and of the regulated secretory organelles within tachyzoites (rhoptries, dense granules, and micronemes) is not known. Subcellular fractionation of extracellular parasites loaded with azithromycin identified a detergent-sensitive vesicular compartment of intermediate density in which a portion of the intracellular drug accumulated (data not shown). Furthermore, when disrupted parasites were fractionated on a self-forming Percoll gradient, nearly 1/3 of the total azithromycin recovered was found in a single peak near the top of the gradient rather than being uniformly distributed throughout the gradient, as would be seen with a strictly cytoplasmic distribution (data not shown). These fractions of compartmentalized drug within T. gondii may represent antibiotic sequestered within structures previously characterized as lysosome-like (29) .
The mechanism of action of azithromycin or other macrolides against intracellular T. gondii remains open to speculation, as does the mechanism for macrolide resistance. Nonetheless, this study indicates that achieving high concentrations of antibiotic within infected cells does not of itself guarantee effective concentration of the drug to the specific intracellular target of a pathogen within such a cell.
